Literature DB >> 19375162

Effects of the LHRH antagonist Cetrorelix on the brain function in mice.

Gyula Telegdy1, Masaru Tanaka, Andrew V Schally.   

Abstract

The decapeptide Cetrorelix, an LHRH antagonist, inhibits gonadotropin and sex steroid secretion. Cetrorelix is used for IVF-ET procedures and for the treatment of patients with prostate carcinoma, benign prostatic hyperplasia, endometriosis, leiomyomas and, ovarian cancer. However little is known about the effects of Cetrorelix on the brain function. In the present work the influence of Cetrorelix on different aspects of the brain function was studied following its administration into the lateral brain ventricle in mice. The effects tested included the impairment of the consolidation of a passive avoidance reflex caused by beta-amyloid 25-35, anxiolytic action in the plus-maze, antidepressive action in a forced swimming test and a tail suspension test and open-field behavior. In the passive avoidance test, beta-amyloid 25-35 administered immediately after the learning trial impaired the consolidation of passive avoidance learning. Cetrorelix fully blocked the impairment of the consolidation of passive avoidance learning when given icv 30 min following beta-amyloid 25-35 administration. If beta-amyloid 25-35 and Cetrorelix icv were given simultaneously, the Cetrorelix attenuated, but did not block the action of the beta-amyloid 25-35. Cetrorelix elicited anxiolytic action in the plus-maze, depending on the dose used. In the forced swimming and tail suspension tests, Cetrorelix demonstrated antidepressive-like action. Concerning open-field behavior, Cetrorelix displayed no action on locomotion, rearing or grooming. The results demonstrate that Cetrorelix affects brain function: and is able to correct the impairment of the memory consolidation caused by beta-amyloid 25-35. Cetrorelix also elicits anxiolytic and antidepressive action, but it does not influence the open-field activity. Further experimental work with Cetrorelix is necessary, but the results imply the possible merit of a clinical trial with Cetrorelix in patients with anxiety, depression and Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375162     DOI: 10.1016/j.npep.2009.03.001

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  13 in total

Review 1.  Luteinizing hormone: Evidence for direct action in the CNS.

Authors:  Jeffrey A Blair; Sabina Bhatta; Henry McGee; Gemma Casadesus
Journal:  Horm Behav       Date:  2015-07-12       Impact factor: 3.587

2.  Hypothalamic gonadotropin-releasing hormone (GnRH) receptor neurons fire in synchrony with the female reproductive cycle.

Authors:  Christian Schauer; Tong Tong; Hugues Petitjean; Thomas Blum; Sophie Peron; Oliver Mai; Frank Schmitz; Ulrich Boehm; Trese Leinders-Zufall
Journal:  J Neurophysiol       Date:  2015-06-10       Impact factor: 2.714

3.  CNS luteinizing hormone receptor activation rescues ovariectomy-related loss of spatial memory and neuronal plasticity.

Authors:  Jeffrey A Blair; Sabina Bhatta; Gemma Casadesus
Journal:  Neurobiol Aging       Date:  2019-02-13       Impact factor: 4.673

Review 4.  The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease.

Authors:  Craig S Atwood; Richard L Bowen
Journal:  Horm Behav       Date:  2015-07-16       Impact factor: 3.587

5.  Luteinizing hormone downregulation but not estrogen replacement improves ovariectomy-associated cognition and spine density loss independently of treatment onset timing.

Authors:  Jeffrey A Blair; Russell Palm; Jaewon Chang; Henry McGee; Xiongwei Zhu; Xinglong Wang; Gemma Casadesus
Journal:  Horm Behav       Date:  2015-10-21       Impact factor: 3.587

6.  Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease.

Authors:  Miklos Jaszberenyi; Ferenc G Rick; Luca Szalontay; Norman L Block; Marta Zarandi; Ren-Zhi Cai; Andrew V Schally
Journal:  Aging (Albany NY)       Date:  2012-11       Impact factor: 5.682

Review 7.  Hypothalamic-pituitary-gonadal axis involvement in learning and memory and Alzheimer's disease: more than "just" estrogen.

Authors:  Jeffrey A Blair; Henry McGee; Sabina Bhatta; Russell Palm; Gemma Casadesus
Journal:  Front Endocrinol (Lausanne)       Date:  2015-03-25       Impact factor: 5.555

Review 8.  Luteinizing Hormone Involvement in Aging Female Cognition: Not All Is Estrogen Loss.

Authors:  Sabina Bhatta; Jeffrey A Blair; Gemma Casadesus
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-24       Impact factor: 5.555

Review 9.  Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway.

Authors:  Nóra Török; Masaru Tanaka; László Vécsei
Journal:  Int J Mol Sci       Date:  2020-12-08       Impact factor: 5.923

Review 10.  Crosstalk between Existential Phenomenological Psychotherapy and Neurological Sciences in Mood and Anxiety Disorders.

Authors:  Lehel Balogh; Masaru Tanaka; Nóra Török; László Vécsei; Shigeru Taguchi
Journal:  Biomedicines       Date:  2021-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.